发明名称 Rna interference mediated inhibition of grb2-associated binding protein 2 (gab2) gene expression using short interfering nucleic acid (sina)
摘要 The present invention concerns methods and reagents useful in modulating gene expression in a variety of applications, including use in therapeutic, diagnostic, target validation, and genomic discovery applications. Specifically, the invention relates to small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), doublestranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules capable of mediating RNA interference (RNAi) against target nucleic acid sequences. The small nucleic acid molecules are useful in the treatment of any disease or condition that responds to modulation of gene expression or activity in a cell, tissue, or organism.
申请公布号 AU2003216311(A8) 申请公布日期 2003.09.09
申请号 AU20030216311 申请日期 2003.02.18
申请人 RIBOZYME PHARMACEUTICALS, INCORPORATED 发明人 JAMES MCSWIGGEN;NASSIM USMAN;LEONID BEIGELMAN
分类号 C12N15/09;A61K31/7088;A61K31/7105;A61K31/711;A61K31/7115;A61K31/712;A61K31/7125;A61K31/713;A61K38/00;A61K47/48;A61K48/00;A61P1/00;A61P1/04;A61P1/16;A61P3/00;A61P3/10;A61P11/06;A61P13/08;A61P13/10;A61P13/12;A61P17/00;A61P17/02;A61P19/00;A61P19/02;A61P21/00;A61P25/00;A61P25/02;A61P25/28;A61P27/02;A61P27/16;A61P29/00;A61P31/00;A61P31/04;A61P31/10;A61P31/12;A61P31/14;A61P31/16;A61P31/18;A61P31/20;A61P31/22;A61P35/00;A61P35/02;A61P37/00;A61P37/04;A61P37/06;A61P37/08;A61P43/00;C07H21/02;C07H21/04;C12N15/11;C12N15/113;C12N15/82 主分类号 C12N15/09
代理机构 代理人
主权项
地址